{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:22:37Z","timestamp":1761675757542},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5-6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.2119\/molmed.2009.00163","type":"journal-article","created":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T14:33:28Z","timestamp":1273674808000},"page":"216-221","source":"Crossref","is-referenced-by-count":14,"title":["\u03b1-Galactosidase A-Tat Fusion Enhances Storage Reduction in Hearts and Kidneys of Fabry Mice"],"prefix":"10.1186","volume":"16","author":[{"given":"Koji","family":"Higuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yoshimitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa I.","family":"Rasaiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuwa","family":"Tei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Medin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,17]]},"reference":[{"key":"1605216_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"276","author":"RO Brady","year":"1967","unstructured":"Brady RO, et al. (1967) Enzymatic defect in Fabry\u2019s disease. Ceramidetrihexosidase deficiency. N. Engl. J. Med. 276:1163\u20137.","journal-title":"N. Engl. J. Med."},{"key":"1605216_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, et al. (1995) An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy. N. Engl. J. Med. 333:288\u201393.","journal-title":"N. Engl. J. Med."},{"key":"1605216_CR3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","volume":"105","author":"B Sachdev","year":"2002","unstructured":"Sachdev B, et al. (2002) Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 105:1407\u201311.","journal-title":"Circulation"},{"key":"1605216_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","volume":"146","author":"M Banikazemi","year":"2007","unstructured":"Banikazemi M, et al. (2007) Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann. Intern. Med. 146:77\u201386.","journal-title":"Ann. Intern. Med."},{"key":"1605216_CR5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","volume":"119","author":"F Weidemann","year":"2009","unstructured":"Weidemann F, et al. (2009) Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation. 119:524\u20139.","journal-title":"Circulation"},{"key":"1605216_CR6","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1681\/ASN.2008080870","volume":"20","author":"M West","year":"2009","unstructured":"West M, et al. (2009) Agalsidase alfa and kidney dysfunction in Fabry disease. J. Am. Soc. Nephrol. 20:1132\u20139.","journal-title":"J. Am. Soc. Nephrol."},{"key":"1605216_CR7","doi-asserted-by":"publisher","first-page":"7917","DOI":"10.1073\/pnas.93.15.7917","volume":"93","author":"JA Medin","year":"1996","unstructured":"Medin JA, et al. (1996) Correction in trans for Fabry disease: expression, secretion and uptake of alpha-galactosidase A in patient-derived cells driven by a high-titer recombinant retroviral vector. Proc. Natl. Acad. Sci. U. S. A. 93:7917\u201322.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1605216_CR8","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.1073\/pnas.120177997","volume":"97","author":"T Takenaka","year":"2000","unstructured":"Takenaka T, et al. (2000) Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells. Proc. Natl. Acad. Sci. U. S. A. 97:7515\u201320.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1605216_CR9","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1073\/pnas.061020598","volume":"98","author":"G Qin","year":"2001","unstructured":"Qin G, et al. (2001) Preselective gene therapy for Fabry disease. Proc. Natl. Acad. Sci. U. S. A. 98:3428\u201333.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1605216_CR10","doi-asserted-by":"publisher","first-page":"16909","DOI":"10.1073\/pnas.0407572101","volume":"101","author":"M Yoshimitsu","year":"2004","unstructured":"Yoshimitsu M, et al. (2004) Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proc. Natl. Acad. Sci. U. S. A. 101:16909\u201314.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1605216_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.gt.3302839","volume":"14","author":"M Yoshimitsu","year":"2007","unstructured":"Yoshimitsu M, et al. (2007) Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem\/progenitor cells. Gene Ther. 14:256\u201365.","journal-title":"Gene Ther."},{"key":"1605216_CR12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/90242","volume":"19","author":"H Xia","year":"2001","unstructured":"Xia H, Mao Q, Davidson BL. (2001) The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors. Nat. Biotechnol. 19:640\u20134.","journal-title":"Nat. Biotechnol."},{"key":"1605216_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ymthe.2005.02.031","volume":"12","author":"KO Orii","year":"2005","unstructured":"Orii KO, et al. (2005) Defining the pathway for Tat-mediated delivery of beta-glucuronidase in cultured cells and MPS VII mice. Mol. Ther. 12:345\u201352.","journal-title":"Mol. Ther."},{"key":"1605216_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.bbrc.2005.05.207","volume":"337","author":"KO Lee","year":"2005","unstructured":"Lee KO, et al. (2005) Improved intracellular delivery of glucocerebrosidase mediated by the HIV-1 TAT protein transduction domain. Biochem. Biophys. Res. Commun. 337:701\u20137.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1605216_CR15","doi-asserted-by":"publisher","first-page":"18188","DOI":"10.1074\/jbc.271.30.18188","volume":"271","author":"D Derossi","year":"1996","unstructured":"Derossi D, et al. (1996) Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271:18188\u201393.","journal-title":"J. Biol. Chem."},{"key":"1605216_CR16","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","volume":"272","author":"E Vives","year":"1997","unstructured":"Vives E, Brodin P, Lebleu B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272:16010\u20137.","journal-title":"J. Biol. Chem."},{"key":"1605216_CR17","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.micinf.2005.11.014","volume":"8","author":"JE King","year":"2006","unstructured":"King JE, Eugenin EA, Buckner CM, Berman JW. (2006) HIV tat and neurotoxicity. Microbes Infect. 8:1347\u201357.","journal-title":"Microbes Infect."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crossref.org\/molmed.2009.00163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2009.00163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T00:40:25Z","timestamp":1554511225000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2009.00163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,17]]},"references-count":17,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["1605216"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2009.00163","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,17]]}}}